Back to search

Denmark· DK-28106784722

Enalaprilmaleat/Lercanidipinhydrochlorid "Viatris"

A enalapril und lercanidipin product containing enalaprilmaleat, lercanidipinhydrochloridhemihydrat, registered in Denmark by Viatris Limited. The same ATC class is registered in 9 of our 19 countries.

ATC C09BB02

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedEnalaprilmaleat/Lercanidipinhydrochlo…ATCC09BB02REGISTER NO.DK-28106784722PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Enalapril und lercanidipin is registered in 9 of 19 countries.

Countries holding a registration under ATC C09BB02 (enalapril und lercanidipin), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 6 of them publish a price we can compare per daily dose

Enalapril und lercanidipin · ATC C09BB02

9 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
ENALAPRILMALEAT, Lercanidipinhydrochloridhemihydrat
Manufacturer
Viatris Limited
Country
Denmark (DK)
ATC code
C09BB02
ATC class
Enalapril und Lercanidipin
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28106784722

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

64 interactions on record for enalapril und lercanidipin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Enalapril und lercanidipin · interactions on record

64 records

64 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a8e44f89-33d0-4fd4-ba3a-afc3128729c5
GET /v1/drugs/a8e44f89-33d0-4fd4-ba3a-afc3128729c5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "filmovertrukne tabletter",
  "source": "dkma",
  "strength": "20+20 mg",
  "auth_role": "RMS",
  "dk_drugid": "28106784722",
  "substance": "ENALAPRILMALEAT, Lercanidipinhydrochloridhemihydrat",
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": false,
  "registration_date_serial": "45665"
}

See everything about enalapril und lercanidipin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.